Skip to main content
Year archive

Dermapharm Holding SE — 2018 filings

All 30 regulatory filings released by Dermapharm Holding SE (DMP) in 2018, sourced directly from the official regulator.

30 Filings
2018 Period
2018 filings (30)
Filing Released Lang
Dermapharm Holding SE reports positive business development in the third quarter of 2018
Earnings Release 9M 2018
2018-11-20 English
Q3 statement / Q3 financial report 2018
Interim / Quarterly Report 9M 2018
2018-11-20 German
Dermapharm Holding SE: Signing of contract for the acquisition of EUROMED S.A.
M&A Activity
2018-11-18 English
Dermapharm Holding SE: Signing of contract for the acquisition of EUROMED S.A.
M&A Activity
2018-11-18 English
Dermapharm takes legal action against approval of a competitor product
Legal Proceedings Report
2018-11-16 English
Konzernabschluss zum Geschäftsjahr vom 01.01.2017 bis zum 31.12.2017
Annual Report FY 2017
2018-10-30 German
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2017 bis zum 31.12.2017
Audit Report / Information FY 2017
2018-10-23 German
Dermapharm Holding SE publishes report for first half of 2018
Earnings Release H1 2018
2018-09-12 English
Report Publication Announcement 2018
Report Publication Announcement
2018-09-06 English
Dermapharm Holding SE:
Earnings Release H1 2018
2018-08-21 English
Dermapharm Holding SE: First Annual General Meeting after successful IPO
AGM Information
2018-06-26 English
Dermapharm Holding SE publishes Q1 2018 report
Report Publication Announcement Q1 2018
2018-05-18 English
Annual financial report 2017
Annual Report FY 2017
2018-05-18 German
Q1 statement / Q1 financial report 2018
Interim / Quarterly Report Q1 2018
2018-05-18 German
Report Publication Announcement 2018
Report Publication Announcement
2018-05-11 English
Dermapharm Holding SE: Dermapharm plans further profitable growth in 2018
Earnings Release FY 2017
2018-04-27 English
Report Publication Announcement 2018
Report Publication Announcement
2018-04-20 English
Dermapharm Holding SE: Dermapharm continued profitable growth in 2017
Earnings Release FY 2017
2018-04-09 English
Konzernabschluss zum Geschäftsjahr vom 01.01.2016 bis zum 31.12.2016
Annual Report FY 2016
2018-03-28 English
DGAP-DD: Dermapharm Holding SE english
Director's Dealing
2018-03-13 English
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements
2018-02-13 English
Declaration of Voting Results & Voting Rights Announcements 2018
Declaration of Voting Results & Voting Rights Announcements
2018-02-09 English
DGAP-DD: Dermapharm Holding SE english
Director's Dealing
2018-02-09 English
DGAP-DD: Dermapharm Holding SE english
Director's Dealing
2018-02-09 English
Dermapharm Holding SE sets offer price at EUR 28.00 per share
Capital/Financing Update
2018-02-08 English
Dermapharm Holding SE sets offer price at EUR 28.00 per share
Share Issue/Capital Change
2018-02-08 English
Release of the Home Member State according to Article 5 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Regulatory Filings
2018-02-08 English
Dermapharm Holding SE sets price range at EUR 26.00 to EUR 30.00 per share for its IPO
Capital/Financing Update
2018-01-26 English
Dermapharm Holding SE: Dermapharm Holding SE plans initial public offering
Capital/Financing Update
2018-01-15 English
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2016 bis zum 31.12.2016
Audit Report / Information FY 2016
2018-01-15 German